pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Repatha · news · pharmadog
← back to Repatha
News mentioning Repatha
11
stories
Aug 27, 26
New data could widen use of AstraZeneca, Amgen immune disease drug
biopharma dive
Aug 20, 26
Scribe’s early-stage IPO standout defies biotech’s derisking trend
biospace
Aug 18, 26
AstraZeneca scores in lung cancer; Sandoz inks a China deal
biopharma dive
Aug 18, 26
Sandoz inks $322M Henlius deal for rights to as many as 10 biosimilars
biospace
Aug 10, 26
Scribe’s Benjamin Oakes on a rare IPO and bringing CRISPR to the masses
biopharma dive
Aug 5, 26
Amgen’s MariTide stands alone after obesity cull while analysts seek more M&A
biospace
Jul 24, 26
Scribe records upsized $129M IPO to bankroll lipid-lowering genetic meds
fiercebiotech
Jul 20, 26
Scribe aims for $96M IPO to fund clinical push for lipid-lowering genetic meds
fiercebiotech
Jul 16, 26
Merck wins first approval of a PCSK9 cholesterol pill
biopharma dive
Jul 16, 26
Merck dives into cholesterol with first FDA approval for oral PCSK9 inhibitor
biospace
Jul 6, 26
Gene editing developer Scribe plots an IPO
biopharma dive
